Article and Video CATEGORIES

Cancer Journey

Search By

Search here for cancer terms and phrases within cancerGRACE.org, and find tons of great information available on the GRACE website.

What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer
gracevideo
Author
GRACE Videos and Articles

"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).

[powerpress]

OAM4971g: Overall Survival Results

Tags
ASCO 2014
erlotinib
Howard Jack West
Howard West
Indiana University School of Medicine
Jack West
Melissa Johnson
Met
MetMab
Nasser Hanna
Northwestern University School of Medicine
onartuzumab
Swedish Cancer Institute
tarceva
targeted treatment

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation

Next Previous link

Previous PostNext Post

Related Content

Advance Directives
Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
2024-25 patient perspectives header
Applications are now closed!... Be a Part of the Patient Perspectives: Clinical Trials Storytelling Program - 2024-25
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
VOD Foro de Pacientes de Terapias Dirigidas en Cáncer de Pulmón 2024 en Español
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Three Year Post Update

Hi Stan,

It's so good to hear you and yours are doing well and that you were able to spend time with both families for Thanksgiving.  I know it meant a...

Three Year Post Update

Hi Stan!  It is good to hear from you -- I am so very happy you are doing well.  I agree with Janine that family and friends - our chosen family...

If You Have Lung Cancer Please Help Build Better Resourses
Those with Lung Cancer Have Opportunity to Help Build Better Resources
Those with Lung Cancer Have Opportunity to Help Build Better Resourses
Stage 4 NSCLC with leptomeningeal carcinomatosis, tagrisso no longer working

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Stage 4 NSCLC with leptomeningeal carcinomatosis, tagrisso no longer working

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Recent Comments

JOIN THE CONVERSATION
Three Year Post Update
So good to hear from you Stan
By dbrock on
Three Year Post Update
Hi Stan,

It's so good to…
By JanineT GRACE … on
Multiple EGFR mutation lung cancer
I could not find any info on…
By JanineT GRACE … on
Stage 4 NSCLC with leptomeningeal carcinomatosis, tagrisso no longer working
Hi elysianfields,

 

That's…
By JanineT GRACE … on